Economic evaluations are increasingly used as tools to inform decision-makers about the cost-effectiveness of health technologies. Such evaluations are often undertaken during the late stages of the technology development (i.e. around the time of product launch or, in some cases, post-launch). However, there is an increasing need for the manufacturers of the technology to appraise the likely cost-effectiveness of the intervention before making decisions on price and indication, as well as to inform the development of clinical trials. The purposes of early economic modelling is to allow the user to determine the relative importance of different parameter inputs, in order to inform decisions on pricing, target populations and prioritisation of further research.
This one-day training session, organised by the York Health Economics Consortium (YHEC), will cover the fundamental aspects of early economic modelling as well as exploring more advanced methods such as value of information analysis.